×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Shyama Computronics and Servic | 0.70 | 0.19 | 0.61 | NA | 4.02 | 30.9 |
| Triochem Products Ltd., | 4.59 | 0.88 | NA | 3.60 | 0 | |
| ROOPA INDUSTRIES LTD. | 316.48 | 7.61 | 307.32 | 0.97 | 54.0 | 26.1 |
| SANDU PHARMACEUTICALS LTD. | 183.97 | 5.56 | 183.73 | 0.57 | 51.8 | 35.2 |
| GUJARAT TERCE LABORATORIES LTD | 127.48 | 10.08 | 126.81 | 1.36 | 50.2 | 17.0 |
Roopa Industries Ltd., with Security Code 530991, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 19.8 | 15.3 | 17.8 | 14.9 | 14.1 | 19.2 | 22.0 | 34.5 | 25.6 | 30.7 |
| Expenses | 18.3 | 14.0 | 17.4 | 13.9 | 12.5 | 18.4 | 21.2 | 33.5 | 24.0 | 29.8 |
| Operating Profit | 1.5 | 1.3 | 0.5 | 1.0 | 1.7 | 0.9 | 0.9 | 1.1 | 1.6 | 1.0 |
| OPM % | 7.78% | 8.51% | 2.71% | 6.93% | 11.99% | 4.64% | 4.2% | 3.05% | 6.42% | 3.18% |
| Other Income | 0.0 | 0.0 | 0.6 | 0.0 | 0.0 | 0.4 | 0.7 | 0.2 | 0.0 | 0.9 |
| Interest | 0.5 | 0.7 | 0.6 | 0.6 | 0.7 | 0.7 | 0.7 | 0.8 | 0.7 | 0.7 |
| Depreciation | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.3 |
| Profit before tax | 0.8 | 0.4 | 0.2 | 0.2 | 0.8 | 0.4 | 0.8 | 0.3 | 0.7 | 1.0 |
| Tax % | 25.7% | 33.1% | 4.6% | 22.5% | 24.8% | 25.7% | 40.3% | 9% | 19.9% | 20.6% |
| Net Profit | 0.6 | 0.3 | 0.2 | 0.2 | 0.6 | 0.3 | 0.5 | 0.3 | 0.6 | 0.8 |
| EPS in Rs | 0.78 | 0.37 | 0.3 | 0.25 | 0.77 | 0.34 | 0.59 | 0.35 | 0.74 | 0.97 |
| Metrics |
|---|
| Sales |
| Expenses |
| Operating Profit |
| OPM % |
| Other Income |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| Net Profit |
| EPS in Rs |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 18% |
| 3 Years: | 35% |
| TTM: | 71% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 20% |
| 3 Years: | 26% |
| TTM: | 60% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 29% |
| 5 Years: | 53% |
| 3 Years: | 47% |
| 1 Year: | 13% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| 1 Year: | 0% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|